M
MapLight Therapeutics, Inc. (MPLT)
NMS – Real vaqt narxi. Valyuta: USD
30.30
+0.21 (0.70%)
Yopilishda: May 12, 2026, 4:00 PM EDT
30.30
0.00 (0.00%)
Bozordan keyin: May 12, 2026, 4:10 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
30.30
+0.21 (0.70%)
Yopilishda: May 12, 2026, 4:00 PM EDT
30.30
0.00 (0.00%)
Bozordan keyin: May 12, 2026, 4:10 PM EDT
MapLight Therapeutics, Inc. – bu markaziy asab tizimi kasalliklari bilan og'rigan bemorlar uchun klinik bosqichdagi biofarmatsevtika kompaniyasidir. Kompaniyaning mahsulotlari orasida shizofreniya va Altsgeymer kasalligi psixozini davolash uchun M 1 /M 4 muskarin agonistining doimiy dozali kombinatsiyasi bo'lgan ML-007C-MA; avtizm spektrining buzilishi bilan bog'liq ijtimoiy muloqot etishmovchiligi va/yoki дразнительностьni davolash uchun ML-004; Parkinson kasalligida harakat buzilishlarini davolash uchun ML-021; neyropsixiatrik holatlarni davolash uchun ML-055; va giperaktivlik, impulsivlik va qo'zg'alish bilan bog'liq buzilishlarni davolash uchun G-protein-bog'langan retseptor 52 musbat allosterik modulatori bo'lgan ML-009 kiradi. Kompaniya, shuningdek, kasallik bilan bog'liq neyronal davrlarni aniqlash va bu davrlarni terapevtik modulyatsiya qilish uchun mo'ljallangan platformani ishlab chiqadi. Kompaniya avval Alvarado Therapeutics, Inc. nomi bilan tanilgan va 2019-yil avgust oyida MapLight Therapeutics, Inc. nomini olgan. MapLight Therapeutics, Inc. 2018-yilda tashkil etilgan va Redvud-Siti, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Anatol Kreitzer Ph.D. | Chief Discovery Officer |
| Dr. Christopher A. Kroeger M.B.A., M.D., Ph.D. | Founder, President, CEO & Director |
| Dr. Erin Pennock Foff M.D., Ph.D. | Chief Medical Officer |
| Dr. James Woodruff Lillie Ph.D. | Chief Scientific Officer |
| Dr. Karl Deisseroth M.D., Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| Dr. Karoly Nikolich Ph.D. | Founder |
| Dr. Robert C. Malenka M.D., Ph.D. | Co-Founder, Member of Scientific Advisory Board & Director |
| Mr. Jonathan Gillis C.P.A. | Chief Administrative & Accounting Officer |
| Mr. Kristopher L. Hanson J.D. | General Counsel & Secretary |
| Mr. Vishwas Setia | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-29 | DEFA14A | d40572ddefa14a.htm |
| 2026-03-26 | 8-K | mplt-20260326.htm |
| 2026-03-26 | 10-K | mplt-20251231.htm |
| 2026-01-09 | 8-K | mplt-20260109.htm |
| 2025-12-04 | 8-K | mplt-20251204.htm |
| 2025-10-29 | 8-K | d89036d8k.htm |
| 2025-10-24 | 8-A12B | d48773d8a12b.htm |